These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33576539)

  • 21. Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.
    Jiang G; Fan C; Zhang X; Dong Q; Wang L; Liu Y; Dai S; Yang L; Zhang Y; Yu J; Wang E
    PLoS One; 2013; 8(3):e59183. PubMed ID: 23536868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorometric detection of EGFR exon 19 deletion mutation in lung cancer cells using graphene oxide.
    Kim DM; Kim DH; Jung W; Lee KY; Kim DE
    Analyst; 2018 Apr; 143(8):1797-1804. PubMed ID: 29561562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
    Luo J; Shen L; Zheng D
    Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insufficiency of peripheral blood as a substitute tissue for detecting EGFR mutations in lung cancer: a meta-analysis.
    Li Z; Zhang Y; Bao W; Jiang C
    Target Oncol; 2014 Dec; 9(4):381-8. PubMed ID: 24623059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
    He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of nano-particulated, water-soluble erlotinib against intracranial metastases of EGFR-mutant lung cancer.
    Kim DH; Choi YJ; Sung KJ; Yoo SA; Sung YH; Kim JK; Choi CM; Yun M; Lee EY; Jin YS; Cook S; Rho JK; Lee JC
    Mol Oncol; 2018 Dec; 12(12):2182-2190. PubMed ID: 30350450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
    O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
    BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 29. The Frequency of Epidermal Growth Factor Receptor (EGFR) mutations in Iraqi patients with Non-Small Cell Lung Cancer (NSCLC).
    Ramadhan HH; Taaban DF; Hassan JK
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):591-596. PubMed ID: 33639678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of whispering gallery mode polymeric micro-optical electric field sensors.
    Ioppolo T; Ötügen V; Ayaz U
    J Vis Exp; 2013 Jan; (71):e50199. PubMed ID: 23407397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
    Song Z; Wang W; Li M; Liu J; Zhang Y
    Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.
    Wang X; Wang G; Hao Y; Xu Y; Zhang L
    Int J Clin Exp Pathol; 2014; 7(7):4310-6. PubMed ID: 25120814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients.
    Wen L; Wang S; Xu W; Xu X; Li M; Zhang Y; Du X; Liu S
    Ann Diagn Pathol; 2020 Dec; 49():151633. PubMed ID: 32977235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment.
    Que D; Xiao H; Zhao B; Zhang X; Wang Q; Xiao H; Wang G
    Cancer Biol Ther; 2016; 17(3):320-7. PubMed ID: 26785777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple and sensitive method for detecting major mutations within the tyrosine kinase domain of the epidermal growth factor receptor gene in non-small-cell lung carcinoma.
    Ohnishi H; Ohtsuka K; Ooide A; Matsushima S; Goya T; Watanabe T
    Diagn Mol Pathol; 2006 Jun; 15(2):101-8. PubMed ID: 16778591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC.
    Penzel R; Sers C; Chen Y; Lehmann-Mühlenhoff U; Merkelbach-Bruse S; Jung A; Kirchner T; Büttner R; Kreipe HH; Petersen I; Dietel M; Schirmacher P
    Virchows Arch; 2011 Jan; 458(1):95-8. PubMed ID: 21057810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.
    Uchida J; Kato K; Kukita Y; Kumagai T; Nishino K; Daga H; Nagatomo I; Inoue T; Kimura M; Oba S; Ito Y; Takeda K; Imamura F
    Clin Chem; 2015 Sep; 61(9):1191-6. PubMed ID: 26206882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.
    Liu X; Lu Y; Zhu G; Lei Y; Zheng L; Qin H; Tang C; Ellison G; McCormack R; Ji Q
    J Clin Pathol; 2013 Dec; 66(12):1065-9. PubMed ID: 23888061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
    Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
    Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer.
    He C; Zheng L; Xu Y; Liu M; Li Y; Xu J
    Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.